Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: Data from 95 consecutive patients treated in a compassionate use program. A study from the swedish chronic lymphocytic leukemia group

Maria Winqvist, Anna Asklid, P. O. Andersson, Karin Karlsson, Claes Karlsson, Birgitta Lauri, Jeanette Lundin, Mattias Mattsson, Stefan Norin, Anna Sandstedt, Lotta Hansson, Anders Österborg

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: Data from 95 consecutive patients treated in a compassionate use program. A study from the swedish chronic lymphocytic leukemia group'. Together they form a unique fingerprint.

Medicine and Dentistry